[1] Kuzuya K. Chemoradiotherapy for uterine cancer: current
status and perspectives [J]. Int J Clin Oncol, 2004,9(6):
458-470.
[2] 唐涛,石翔翔,庞皓文,等. 妇科肿瘤调强放疗摆位方法和误差分
析及与BMI的关系[J].泸州医学院学报,2015,38(5):498-501.
[3] Green JA, Kirwan JM, Tierney JF, et al. Survival and
recurrence after concomitant chemotherapy and radiotherapy
for cancer of the uterine cervix: a systematic review and
meta-analysis [J]. Lancet, 2001,358(9284):781-786.
[4] 康静波.癌症是一种可控可治的慢性病[J].慢性病学杂志,2013,4
(6):401-410.
[5] Petrelli F, De Stefani A, Raspagliesi F, et al. Radiotherapy
with concurrent cisplatin- based doublet or weekly cisplatin
for cervical cancer: a systematic review and metaanalysis
[J]. Gynecol Oncol, 2014,134(1):166-171.
[6] 赵辉,孔为民. 贫血与子宫颈癌预后的关系[J]. 中国临床医学,
2011,5(2):207-208.
[7] Hadjiyannakis S, Buchholz A, Chanoine JP, et al. The
Edmonton Obesity Staging System for Pediatrics: A proposed
clinical staging system for paediatric obesity [J]. Paediatr
Child Health, 2016,21(1):21-26.
[8] Kizer NT, Thaker PH, Gao F, et al. The effects of
body mass index on complications and survival outcomes in
patients with cervical carcinoma undergoing curative chemoradiation
therapy [J]. Cancer, 2011,117(5):948-956.